{
  "symbol": "BFRIW",
  "company_name": "Biofrontera Inc WT",
  "ir_website": "https://investors.biofrontera-us.com/",
  "structured_data": [
    {
      "section_name": "News Articles",
      "links": [
        {
          "title": "Biofrontera Announces New Data on Ameluz® and Xepi® at the American Academy of Dermatology 2024 Annual Meeting",
          "url": "https://investors.biofrontera-us.com/news-events/announcement/ameluz-xepi-data-2024",
          "content": "[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Home](https://www.biofrontera-us.com/)\n  * [About us](https://www.biofrontera-us.com/about-us/mission)Open menu\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n    * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n  * [Products](https://www.biofrontera-us.com/products/portfolio)Open menu\n    * [Product Portfolio](https://www.biofrontera-us.com/products/portfolio)\n  * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n  * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)Open menu\n    * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n    * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n  * [Investors](https://investors.biofrontera-us.com/)Open menu\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n  * [Contact](https://www.biofrontera-us.com/contact)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo.png) ](https://investors.biofrontera-us.com)\n\nX\n\n[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [Home](https://www.biofrontera-us.com/)\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n    * [Products](https://www.biofrontera-us.com/products/portfolio)\n      * [Portfolio](https://www.biofrontera-us.com/products/portfolio)\n    * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n    * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Contact](https://www.biofrontera-us.com/contact)\n  * [IR Menu](#)Open menu\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo-biofrontera.png) ](https://www.biofrontera-us.com/)\n\nX\n\n# Nothing here\n\nIt looks like nothing was found at this location. Maybe try a search?\n\nSearch…\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nInvestor Relationsir@bfinc.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nINVESTOR RELATIONS CONTACTPamela Keck [+49-214-87632-92 ](tel:+49-214-87632-92)us-ir@biofrontera.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n© Copyright 2021, Biofrontera Corp. All rights reserved.\n"
        },
        {
          "title": "Biofrontera Reports Fourth Quarter and Full Year 2023 Financial Results",
          "url": "https://investors.biofrontera-us.com/news-events/announcement/q4-2023-results",
          "content": "[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Home](https://www.biofrontera-us.com/)\n  * [About us](https://www.biofrontera-us.com/about-us/mission)Open menu\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n    * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n  * [Products](https://www.biofrontera-us.com/products/portfolio)Open menu\n    * [Product Portfolio](https://www.biofrontera-us.com/products/portfolio)\n  * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n  * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)Open menu\n    * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n    * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n  * [Investors](https://investors.biofrontera-us.com/)Open menu\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n  * [Contact](https://www.biofrontera-us.com/contact)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo.png) ](https://investors.biofrontera-us.com)\n\nX\n\n[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [Home](https://www.biofrontera-us.com/)\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n    * [Products](https://www.biofrontera-us.com/products/portfolio)\n      * [Portfolio](https://www.biofrontera-us.com/products/portfolio)\n    * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n    * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Contact](https://www.biofrontera-us.com/contact)\n  * [IR Menu](#)Open menu\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo-biofrontera.png) ](https://www.biofrontera-us.com/)\n\nX\n\n# Nothing here\n\nIt looks like nothing was found at this location. Maybe try a search?\n\nSearch…\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nInvestor Relationsir@bfinc.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nINVESTOR RELATIONS CONTACTPamela Keck [+49-214-87632-92 ](tel:+49-214-87632-92)us-ir@biofrontera.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n© Copyright 2021, Biofrontera Corp. All rights reserved.\n"
        },
        {
          "title": "Biofrontera Announces Supplemental NDA Approval for Ameluz® for actinic keratosis",
          "url": "https://investors.biofrontera-us.com/news-events/announcement/snda-ameluz",
          "content": "[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Home](https://www.biofrontera-us.com/)\n  * [About us](https://www.biofrontera-us.com/about-us/mission)Open menu\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n    * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n  * [Products](https://www.biofrontera-us.com/products/portfolio)Open menu\n    * [Product Portfolio](https://www.biofrontera-us.com/products/portfolio)\n  * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n  * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)Open menu\n    * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n    * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n  * [Investors](https://investors.biofrontera-us.com/)Open menu\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n  * [Contact](https://www.biofrontera-us.com/contact)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo.png) ](https://investors.biofrontera-us.com)\n\nX\n\n[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [Home](https://www.biofrontera-us.com/)\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n    * [Products](https://www.biofrontera-us.com/products/portfolio)\n      * [Portfolio](https://www.biofrontera-us.com/products/portfolio)\n    * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n    * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Contact](https://www.biofrontera-us.com/contact)\n  * [IR Menu](#)Open menu\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo-biofrontera.png) ](https://www.biofrontera-us.com/)\n\nX\n\n# Nothing here\n\nIt looks like nothing was found at this location. Maybe try a search?\n\nSearch…\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nInvestor Relationsir@bfinc.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nINVESTOR RELATIONS CONTACTPamela Keck [+49-214-87632-92 ](tel:+49-214-87632-92)us-ir@biofrontera.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n© Copyright 2021, Biofrontera Corp. All rights reserved.\n"
        },
        {
          "title": "Biofrontera's Xepi® Approved for Treatment of Impetigo",
          "url": "https://investors.biofrontera-us.com/news-events/announcement/xepi-approval",
          "content": "[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Home](https://www.biofrontera-us.com/)\n  * [About us](https://www.biofrontera-us.com/about-us/mission)Open menu\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n    * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n  * [Products](https://www.biofrontera-us.com/products/portfolio)Open menu\n    * [Product Portfolio](https://www.biofrontera-us.com/products/portfolio)\n  * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n  * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)Open menu\n    * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n    * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n  * [Investors](https://investors.biofrontera-us.com/)Open menu\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n  * [Contact](https://www.biofrontera-us.com/contact)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo.png) ](https://investors.biofrontera-us.com)\n\nX\n\n[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [Home](https://www.biofrontera-us.com/)\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n    * [Products](https://www.biofrontera-us.com/products/portfolio)\n      * [Portfolio](https://www.biofrontera-us.com/products/portfolio)\n    * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n    * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Contact](https://www.biofrontera-us.com/contact)\n  * [IR Menu](#)Open menu\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo-biofrontera.png) ](https://www.biofrontera-us.com/)\n\nX\n\n# Nothing here\n\nIt looks like nothing was found at this location. Maybe try a search?\n\nSearch…\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nInvestor Relationsir@bfinc.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nINVESTOR RELATIONS CONTACTPamela Keck [+49-214-87632-92 ](tel:+49-214-87632-92)us-ir@biofrontera.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n© Copyright 2021, Biofrontera Corp. All rights reserved.\n"
        }
      ]
    },
    {
      "section_name": "Financial Reports",
      "links": [
        {
          "title": "2023 Annual Report",
          "url": "https://investors.biofrontera-us.com/financial-reports/annual-report-2023.pdf",
          "content": "Error extracting PDF content: 404 Client Error: Not Found for url: https://investors.biofrontera-us.com/financial-reports/annual-report-2023.pdf"
        },
        {
          "title": "Q4 2023 Earnings Call Presentation",
          "url": "https://investors.biofrontera-us.com/financial-reports/q4-2023-presentation.pdf",
          "content": "Error extracting PDF content: 404 Client Error: Not Found for url: https://investors.biofrontera-us.com/financial-reports/q4-2023-presentation.pdf"
        }
      ]
    },
    {
      "section_name": "Press Releases",
      "links": [
        {
          "title": "Biofrontera Highlights at the 2023 Business Summit",
          "url": "https://investors.biofrontera-us.com/press-releases/business-summit-2023",
          "content": "[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Home](https://www.biofrontera-us.com/)\n  * [About us](https://www.biofrontera-us.com/about-us/mission)Open menu\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n    * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n  * [Products](https://www.biofrontera-us.com/products/portfolio)Open menu\n    * [Product Portfolio](https://www.biofrontera-us.com/products/portfolio)\n  * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n  * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)Open menu\n    * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n    * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n  * [Investors](https://investors.biofrontera-us.com/)Open menu\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n  * [Contact](https://www.biofrontera-us.com/contact)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo.png) ](https://investors.biofrontera-us.com)\n\nX\n\n[ ![logo-biofrontera](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-biofrontera-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb68.png) ](https://www.biofrontera-us.com/)\n\n  * [Corporate Menu](#)Open menu\n    * [Home](https://www.biofrontera-us.com/)\n    * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [About us](https://www.biofrontera-us.com/about-us/mission)\n      * [Leadership](https://www.biofrontera-us.com/about-us/leadership)\n    * [Products](https://www.biofrontera-us.com/products/portfolio)\n      * [Portfolio](https://www.biofrontera-us.com/products/portfolio)\n    * [Research](https://www.biofrontera-us.com/research/product-pipeline)\n    * [Career](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Who are the people of Biofrontera?](https://www.biofrontera-us.com/career/who-are-the-people-of-biofrontera)\n      * [Job openings](https://www.biofrontera-us.com/career/job-openings)\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Contact](https://www.biofrontera-us.com/contact)\n  * [IR Menu](#)Open menu\n    * [Investors](https://investors.biofrontera-us.com/)\n    * [Corporate Information](https://investors.biofrontera-us.com/corporate-information/)\n    * [News & Events](https://investors.biofrontera-us.com/news-events/)\n    * [Stock Information](https://investors.biofrontera-us.com/stock-information/)\n    * [Financial Reports](https://investors.biofrontera-us.com/financial-reports/)\n    * [SEC Filings](https://investors.biofrontera-us.com/sec-filings/)\n    * [Contacts and Email Alerts](https://investors.biofrontera-us.com/contacts-and-email-alerts/)\n\n\n\n[ ![](https://investors.biofrontera-us.com/wp-content/uploads/2021/07/logo-biofrontera.png) ](https://www.biofrontera-us.com/)\n\nX\n\n# Nothing here\n\nIt looks like nothing was found at this location. Maybe try a search?\n\nSearch…\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nInvestor Relationsir@bfinc.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n![logo-lgt-white](https://investors.biofrontera-us.com/wp-content/uploads/elementor/thumbs/logo-lgt-white-peg8pj14lqgfmpirltknyotvhn6v9niva99agihb3q.png)\n\nBiofrontera is a highly innovative specialty dermatology company, focused on the fields of photodynamic therapy and topical antibiotics. In collaboration with healthcare providers, we are fully committed to advancing treatment options and patient care. \n\n120 Presidential Way, Suite 330Woburn, MA 01801[ 1-781-245-1325](tel:1-781-245-1325)info-us@biofrontera.com\n\nINVESTOR RELATIONS CONTACTPamela Keck [+49-214-87632-92 ](tel:+49-214-87632-92)us-ir@biofrontera.com \n\n  * [ ](https://www.linkedin.com/company/biofrontera-inc)\n\n\n\n© Copyright 2021, Biofrontera Corp. All rights reserved.\n"
        }
      ]
    }
  ]
}